California Nanotechnologies Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA1304921010
CAD
0.35
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About California Nanotechnologies Corp. stock-summary
stock-summary
California Nanotechnologies Corp.
Pharmaceuticals & Biotechnology
California Nanotechnologies Corp. is engaged in the development of nanocrystalline materials through grain size reduction. The Company focuses on commercialization efforts. It targets various markets, such as consumer electronics, aerospace, defense, automotive, oil and gas, medical, and sports and recreation. It supplies thermal spray powders that are utilized for wear, corrosion and thermal barrier coatings. Powders are available for plasma, high velocity oxygen fuel (HVOF) and particle tracking analysis (PTA) welding. Its Spark Plasma Sintering (SPS) allows for the application of temperature and pressure through high-density pulsed current within a controlled atmosphere. SPS applications include semiconductors, fine ceramics, thermoelectrics, electronics, nanophases, hard alloy tools, biomaterials, porous materials and molds and dies. To provide its products, the Company has an array of production facilities, including cold forging, cryogenic milling and spray drying.
Company Coordinates stock-summary
Company Details
17220 Edwards Rd , CERRITOS CA : 90703-2426
stock-summary
Tel: 1 562 9915211
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Eric Eyerman
Chief Executive Officer, Director
Mr. Roger Dent
Director
Mr. Sebastien Goulet
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - May 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 19 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-68.24%

stock-summary
Price to Book

5.71